Evidence map›Paper›PMID 16648257›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

Dimerization and interactions of Brucella suis VirB8 with VirB4 and VirB10 are required for its biological activity.

Athanasios Paschos, Gilles Patey, Durga Sivanesan, Chan Gao, Richard Bayliss, Gabriel Waksman, David O'callaghan, Christian Baron

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. ThemicroLife · 2025
    Review
  3. Review
  4. Uncovering the Hidden Credentials ofMicrobiology and molecular biology reviews : MMBR · 2021
    Review
  5. Bacteria-Killing Type IV Secretion Systems.Frontiers in microbiology · 2019
    Review
  6. VirB8 homolog TraE from plasmid pKM101 forms a hexameric ring structure and interacts with the VirB6 homolog TraD.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. AFrontiers in cellular and infection microbiology · 2016
    Article
  14. Article
  15. Review
  16. Review
  17. Isolation of bacterial type IV machine subassemblies.Methods in molecular biology (Clifton, N.J.) · 2013
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Athanasios PaschosDepartment of Biology, McMaster University, 1280 Main Street West, Hamilton, ON, Canada L8S 4K1.
Gilles Patey
Durga Sivanesan
Chan Gao
Richard Bayliss
Gabriel Waksman
David O'callaghan
Christian Baron

Funding

Wellcome Trust 065932
6 · The paper itself

Abstract

VirB8-like proteins are essential components of type IV secretion systems, bacterial virulence factors that mediate the translocation of effector molecules from many bacterial pathogens into eukaryotic cells. Based on cell biological, genetic, and x-ray crystallographic data, VirB8 was proposed to undergo multiple protein-protein interactions to mediate assembly of the translocation machinery. Here we report the results of a structure-function analysis of the periplasmic domain of VirB8 from the mammalian pathogen Brucella suis, which identifies amino acid residues required for three protein-protein interactions. VirB8 variants changed at residues proposed to be involved in dimerization, and protein-protein interactions were purified and characterized in vitro and in vivo. Changes at M102, Y105, and E214 affected the self-association as measured by analytical ultracentrifugation and gel filtration. The interaction with B. suis VirB10 was reduced by changes at T201, and change at R230 inhibited the interaction with VirB4 in vitro. The in vivo functionality of VirB8 variants was determined by complementation of growth in macrophages by a B. suis virB8 mutant and by using a heterologous assay of type IV secretion system assembly in Agrobacterium tumefaciens. Changes at Y105, T201, R230, and at several other residues impaired the in vivo function of VirB8, suggesting that we have identified interaction sites of relevance in the natural biological context.

Indexed as

Bacterial ProteinsBrucella suisCell ProliferationCrystallography, X-RayDimerizationModels, MolecularMutationProtein BindingProtein Structure, QuaternaryProtein Structure, SecondarySolventsBacterial ProteinsSolvents

Identifiers

PMID16648257
PMCPMC1464329

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.